
Calvert Laboratories is a world-class contract research organization specializing in preclinical testing.
Experienced and Accredited
Our senior scientists have over 100 years of experience in the design and submission of preclinical programs to regulatory agencies all over the world.
Wide Range of Therapeutic Areas
Between the years 2007 and 2010, we served over 400 different clients that are researching technologies designed to advance treatment of diseases like glaucoma, cardiovascular disease, cancer, diabetes, and many more.
A High Level of Service
Our reputation for excellent quality standards and our commitment to provide clients with the opportunity to monitor study results as they occur sets us apart from other CROs.
Your Best Chance for Success
Contact Calvert today about scheduling your preclinical trial, and take advantage of our scientific, regulatory submission, and drug candidate progression expertise.
![]()
CLIENT TESTIMONIES
“We had never heard of Calvert, but decided to place our entire program with them. All milestones and timelines have been met, the IND filed on time, and the NDA supportive studies performed exceedingly well. It has been and continues to be a pleasure to work with Calvert.”
- M.R., Director of Toxicology
“Calvert saved our program and our company. We went with another CRO originally because it was cheaper and we had very bad results. Without Calvert we would be out of business today.”
- P.M., VP of Toxicology
Outsourcing-Pharma.com
Jubilant buys Lilly out of early-phase JV
26 Jan 2012 | 7:08 am EST
DHL gains license for packing & labelling medical devices
26 Jan 2012 | 6:46 am EST
Contract manufacturing round-up
26 Jan 2012 | 6:20 am EST
Toxicology News
Toxin in latest herbal high can cause liver damage
21 Jan 2012 | 12:59 pm EST
Woman dies from accidental overdose
20 Jan 2012 | 2:53 pm EST
Tymoshenko being poisoned?
17 Jan 2012 | 8:34 pm EST
Pharmacology News
Clinical Pharmacology Advice Network opens in Avon Park
22 Jan 2012 | 11:12 am EST
Exacerbation of Acetaminophen Hepatotoxicity by the Anthelmentic Drug Fenbendazole
20 Jan 2012 | 7:50 pm EST
Evaluation of warfarin drug interaction listings in US product...
15 Oct 2011 | 2:12 pm EDT
Immunology News
La Jolla Institute scientist takes quest to conquer Type 1 diabetes to the next level
23 Jan 2012 | 5:09 pm EST
New Spring Air mattresses certified as asthma, allergy friendly
23 Jan 2012 | 12:59 pm EST
Molecular fingerprinting of the intestinal microbiota of infants in...
23 Jan 2012 | 8:50 am EST





